Jonathan L Marcus, the Sr MD General Counsel of $CME, sold 376 shares of the company on 09-16-2025 for an estimated $97,368. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.2% of their shares of this class of stock. Following this trade, they now own 8,537 shares of this class of $CME stock.
$CME Insider Trading Activity
$CME insiders have traded $CME stock on the open market 21 times in the past 6 months. Of those trades, 4 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $CME stock by insiders over the last 6 months:
- SUNIL CUTINHO (Chief Information Officer) has made 0 purchases and 2 sales selling 11,896 shares for an estimated $3,229,444.
- DEREK SAMMANN (Sr MD Gl Hd Commodities Mkts) has made 0 purchases and 2 sales selling 4,650 shares for an estimated $1,304,847.
- LARRY G GERDES has made 0 purchases and 3 sales selling 4,000 shares for an estimated $1,060,441.
- CHARLES P CAREY has made 0 purchases and 3 sales selling 3,500 shares for an estimated $950,356.
- PHYLLIS M LOCKETT sold 1,060 shares for an estimated $294,552
- DENNIS SUSKIND sold 1,000 shares for an estimated $271,280
- JONATHAN L MARCUS (Sr MD General Counsel) has made 0 purchases and 2 sales selling 766 shares for an estimated $205,593.
- WILLIAM R SHEPARD has made 4 purchases buying 541 shares for an estimated $144,330 and 0 sales.
- DANIEL G KAYE sold 500 shares for an estimated $141,209
- TIMOTHY FRANCIS MCCOURT (Sr MD Global Head Equity & FX) sold 379 shares for an estimated $98,475
- MARTIN J GEPSMAN sold 300 shares for an estimated $81,951
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CME Hedge Fund Activity
We have seen 843 institutional investors add shares of $CME stock to their portfolio, and 718 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 3,048,375 shares (+305.7%) to their portfolio in Q2 2025, for an estimated $840,193,117
- BLACKROCK, INC. removed 2,571,288 shares (-7.9%) from their portfolio in Q2 2025, for an estimated $708,698,398
- GAMMA INVESTING LLC removed 1,850,590 shares (-99.6%) from their portfolio in Q2 2025, for an estimated $510,059,615
- GQG PARTNERS LLC added 1,368,647 shares (+62.1%) to their portfolio in Q2 2025, for an estimated $377,226,486
- MORGAN STANLEY removed 1,124,021 shares (-10.6%) from their portfolio in Q2 2025, for an estimated $309,802,668
- CAPITAL WORLD INVESTORS removed 1,109,855 shares (-11.4%) from their portfolio in Q2 2025, for an estimated $305,898,235
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 983,290 shares (-70.5%) from their portfolio in Q2 2025, for an estimated $271,014,389
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CME Congressional Stock Trading
Members of Congress have traded $CME stock 6 times in the past 6 months. Of those trades, 4 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CME stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 3 times. They made 2 purchases worth up to $30,000 on 08/11, 07/22 and 1 sale worth up to $15,000 on 08/14.
- REPRESENTATIVE VAL T. HOYLE purchased up to $15,000 on 05/21.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CME Analyst Ratings
Wall Street analysts have issued reports on $CME in the last several months. We have seen 3 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Oppenheimer issued a "Outperform" rating on 07/24/2025
- Piper Sandler issued a "Overweight" rating on 07/15/2025
- Morgan Stanley issued a "Overweight" rating on 04/24/2025
- JP Morgan issued a "Underweight" rating on 04/24/2025
- B of A Securities issued a "Underperform" rating on 04/02/2025
To track analyst ratings and price targets for $CME, check out Quiver Quantitative's $CME forecast page.
$CME Price Targets
Multiple analysts have issued price targets for $CME recently. We have seen 11 analysts offer price targets for $CME in the last 6 months, with a median target of $285.0.
Here are some recent targets:
- Alex Kramm from UBS set a target price of $285.0 on 09/08/2025
- Owen Lau from Oppenheimer set a target price of $303.0 on 07/24/2025
- Benjamin Budish from Barclays set a target price of $298.0 on 07/24/2025
- Patrick Moley from Piper Sandler set a target price of $296.0 on 07/15/2025
- Christopher Allen from Citigroup set a target price of $275.0 on 07/03/2025
- Kenneth Worthington from JP Morgan set a target price of $211.0 on 04/24/2025
- Kyle Voigt from Keefe, Bruyette & Woods set a target price of $273.0 on 04/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
